Every material Form 8-K Quanex Building Products filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Quanex reported net sales of $501.8 million for the three months ended July 31, 2026, up 1.3% from $495.3 million a year earlier, and net income of $26.5 million, or $0.58 per diluted share, compared with a net loss of $276.0 million in the prior-year quarter. The prior-year loss included a $302.3 million non-cash goodwill impairment, so the year-over-year swing largely reflects that charge.
Net sales were $501.8 million, up 1.3% from $495.3 million, mainly due to favorable pricing, partly offset by IEEPA tariff reimbursements to customers.
Diluted EPS was $0.58 versus a loss of $6.04 a year earlier; adjusted diluted EPS was $0.79 versus $0.69.
The company repaid $42.25 million of debt in the quarter and repurchased 99,786 shares for about $1.7 million; about $28.7 million remained under its authorization as of July 31, 2026.
Management will host a conference call on Friday, September 4, 2026, at 11:00 a.m. ET.
Quanex reported results for the three months ended April 30, 2026. Net sales rose 2.2% to $462.4 million, but net income fell to $3.4 million, or $0.07 per diluted share, from $20.5 million, or $0.44, as rapid cost increases and lower volumes pressured margins. Management expects to recover some of the shortfall in the second half if volumes follow normal seasonality and inflationary pressure subsides.
Net sales were $462.4 million, up from $452.5 million, mainly from pricing, including tariff-related recoveries, and foreign exchange.
Gross margin was 25.5% versus 29.0% a year earlier; adjusted diluted EPS was $0.25 versus $0.63.
Adjusted EBITDA was $44.2 million versus $63.1 million in the prior-year quarter.
As of April 30, 2026, total debt was $715.0 million, leverage was 3.1x net debt to LTM adjusted EBITDA, and liquidity was $328.6 million.
Quanex reported first quarter fiscal 2026 results for the three months ended January 31, 2026, with net sales up 2.3% to $409.1 million and a narrower net loss of $4.1 million. Adjusted diluted EPS fell to a loss of $0.01 from earnings of $0.19 a year earlier, and Adjusted EBITDA declined to $27.4 million from $38.5 million. The company also issued fiscal 2026 guidance of $1.84 billion to $1.87 billion in net sales and $240 million to $245 million in Adjusted EBITDA, and said it expects to be a net borrower in the first half of the year.
Net sales rose to $409.1 million from $400.0 million, mainly due to foreign exchange translation and pass-through of tariffs.
Net loss narrowed to $4.1 million, or $0.09 per diluted share, from $14.9 million, or $0.32 per diluted share, a year earlier.
Adjusted EBITDA fell to $27.4 million from $38.5 million, and Adjusted EBITDA margin was 6.7% versus 9.6%.
Fiscal 2026 guidance calls for net sales of $1.84 billion to $1.87 billion and Adjusted EBITDA of $240 million to $245 million, with the first half expected to be more challenging than the first half of 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Quanex Building Products filing is on SEC EDGAR ↗. 8-K briefs of other companies →